DEBUT BIOTECH
Debut Biotech is a biotechnology company that focuses on providing specialty enzyme solutions combined with continuous manufacturing. It combines the power of enzymes with continuous manufacturing to create and modify small and large molecules for a wide range of industries and applications. The company was founded in 2019 and is based in San Diego, California.
DEBUT BIOTECH
Industry:
Biotechnology Manufacturing Therapeutics
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.debutbiotech.com
Total Employee:
1+
Status:
Active
Total Funding:
26.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
AquaBounty Technologies
AquaBounty Technologies is a biotechnology company that focuses on improving productivity in commercial aquaculture.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Bluepha
Bluepha is a biomanufacturing and material innovation company providing breakthrough products with competitive differentiation.
Bota Biosciences
Bota is an industrial synthetic biotechnology company with a vision to program biological systems for clean and efficient bio-manufacturing.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Conagen
Conagen, a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries.
Integrated CBD
Integrated CBD is a vertically-integrated, institutional quality and scale supplier of organically grown hemp and hemp-derived CBD.
Nascent Biotech
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies.
insempra.bio
insempra.bio is a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Board_member
Current Employees Featured
Joshua Britton CEO @ Debut Biotech
CEO
2019-04-01
Founder
Investors List
Material Impact Fund
Material Impact Fund investment in Series A - Debut Biotech
KdT Ventures
KdT Ventures investment in Series A - Debut Biotech
Cultivian Sandbox Ventures
Cultivian Sandbox Ventures investment in Series A - Debut Biotech
Fine Structure Venture
Fine Structure Venture investment in Series A - Debut Biotech
Cantos
Cantos investment in Series A - Debut Biotech
Humboldt Fund
Humboldt Fund investment in Series A - Debut Biotech
ACVC Partners
ACVC Partners investment in Series A - Debut Biotech
Air Force Research Laboratory
Air Force Research Laboratory investment in Grant - Debut Biotech
FTW Ventures
FTW Ventures investment in Seed Round - Debut Biotech
KdT Ventures
KdT Ventures investment in Seed Round - Debut Biotech
Official Site Inspections
http://www.debutbiotech.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Debut Biotech"
Debut
Not another synthetic biotech company. We use science, strategy and creativity to build big businesses that put humanity ahead.See details»
Debut - Crunchbase Company Profile & Funding
Organization. Debut . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Debut is an …See details»
Debut - 2025 Company Profile & Funding - Tracxn
Mar 14, 2025 Debut - Provider and manufacturer of enzymes for biotherapeutic creation and modification. Raised a total funding of $106M over 7 rounds from 15 investors. Founded by …See details»
DIC and Debut Biotech Advance and Scale ... - DIC Corporation
Jul 29, 2022 DIC Corporation is one of the world’s leading fine chemicals companies and the core of the DIC Group, a multinational organization comprising over 190 companies around …See details»
Our Integrated Creation Model | Debut
Our iteration style is rapid and frictionless. By eliminating the sluggish pace of bureaucracy, we have given ourselves the freedom to develop, design, and build at an unprecedented …See details»
Debut Biotechnology - Overview, News & Similar companies
View Debut Biotechnology (www.debutbiotech.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Debut Biotechnology, Inc. - San Diego, USA - bionity.com
Aug 2, 2022 debutbiotech.com. Contact. Profile News. Contact. About Debut Biotechnology. Debut Biotech is unlocking and delivering high performance ingredients through advanced, cell-free biomanufacturing. Our platform …See details»
Debut Biotech
Debut Biotech is combining creativity with science to make breakthrough biotechnology solutions. Biotechnology will become one of the more important brand strategies in coming years as …See details»
DIC and Debut Biotech Advance and Scale Biomanufacturing of …
TOKYO, JAPAN—July 29, 2022—DIC Corporation (DIC) announced the start of the second phase of a joint development agreement with California-based biotech startup Debut …See details»
Debut Biotech - Cultivian Sandbox Ventures
Jan 9, 2024 Debut Biotech is dedicated to unlocking natural products through sustainable biomanufacturing. Their unique biomanufacturing platform harnesses natural cell-free …See details»
Debut Biotech CEO and Key Executive Team | Craft.co
Debut Biotech's Founder and Chief Executive Officer is Joshua Britton. Other executives include Nicholas Brideau, Senior Vice President, R&D; Mark Wall, Chief Scientific Officer and 6 …See details»
Debut Biotech - Craft
Debut Biotech has 5 employees at their 1 location and $2.6 m in total funding,. See insights on Debut Biotech including office locations, competitors, revenue, financials, executives, …See details»
DIC Invests in U.S. Sustainable Biotech Innovator Debut
Jun 2, 2023 DIC Corporation is one of the world’s leading fine chemicals companies and the core of the DIC Group, a multinational organization comprising over 190 companies, including …See details»
Debut Technology - VentureRadar
"Debut Biotech, a UC Irvine spin-off, uses a proprietary platform technology we have pioneered called cell-free biomanufacturing. We use cell-free biomanufacturing to unlock and overcome …See details»
Debut Biotechnology (USA) Funding: $66.2M
Mar 5, 2025 Debut is an innovation company focused on developing innovative biomanufacturing processes for US Army to onshore foreign production of precursors critical to …See details»
Debut Biotechnology Company Profile -Sales, Contacts, …
Debut Biotechnology is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
Debut and DIC Corporation Establish Strategic Partnership for ...
Mar 21, 2023 To learn more about Debut Biotech, visit www.debutbiotech.com. ... a multinational organization comprising over 190 companies around the globe, including Sun Chemical …See details»
Debut (Discovery Tools) - PitchBook
Sep 15, 2020 Debut (Discovery Tools) General Information Description. Operator of a biotechnology platform intended to develop climate-positive products for various industries. …See details»
Debut Biotech Raises $22.6M Series A to Commercialize High …
Aug 13, 2021 Novel ingredients bring unique advantages to cosmetic, food, and health and wellness markets in one of the largest Series A financing rounds in synthetic biology spaceSee details»
Debut Biotech makes its entrance with a $22M series A for cell …
Aug 12, 2021 Debut Biotech wants to be the next big biomanufacturer, and the two-year-old startup thinks cell-free enzymes are the way forward. The company raised $22.6 million in …See details»